Figure 2.
Trial profile. Three of the 76 included patients dropped out before receiving the study medication. All remaining 73 patients completed the trial and were analyzed for the primary end point.
Trial profile. Three of the 76 included patients dropped out before receiving the study medication. All remaining 73 patients completed the trial and were analyzed for the primary end point.
